Fluoroscopic intraoperative imaging is performed with the aid of C-arms during challenging surgical and emergency care procedures. They have radiographic capabilities and image intensifiers, which help to produce high-resolution X-ray images and enable surgeons to track the course of surgery in real time. Additionally, they aid in the visualization of abdominal and thoracic aortic aneurysm repair, gastroenterology, neurostimulation, percutaneous valve replacements, and kidney drainage. They are, therefore, widely used in orthopedics, traumatology, cardiology, vascular surgery, pain management, and neurological procedures everywhere in the world. The market for c-arms will grow at a strong CAGR of 4.96%, valued at $1684.11 million in 2021 and projected to rise to $2603 million by 2030.
Market Overview
Drivers
The market for C-arms is expanding due to the introduction of new technologies and rising demand for minimally invasive medical procedures like surgery. Small incisions are made on body parts during minimally invasive surgeries, minimizing access to the internal organs. The growth of the market is fueled by the use of the C-arms device, which gives surgeons real-time images and visual guidance while performing surgeries.
Restraints
The market for C-arms is expanding as a result of new technological advancements and rising interest in surgeries and other minimally invasive medical procedures. The internal organs can only be reached through very small incisions made during minimally invasive surgeries. The C-arms device is used to give surgeons real-time images and visual guidance while performing surgeries, which spurs the market's expansion.
Opportunities
The growing elderly population and altering lifestyles are contributing to the rising prevalence of chronic diseases like cancer, diabetes, respiratory conditions, and others. The prevalence of chronic illnesses necessitates surgical intervention. Since most surgeries are minimally invasive and require C-Arms to access internal organs during operations, the rising demand for surgical procedures is anticipated to fuel the growth of the C-arms market over the forecast period.
Challenges
Financial constraints are being imposed by the healthcare industry's current economic situation. Considering that they have a low return on investment policies, this forces healthcare administrators to limit the purchase of expensive medical equipment. During the projected period, this is anticipated to pose a threat to the market's expansion for C-arms.
Segmentation analysis
Fixed and mobile products are separated under the product type segment. With a market share of about 63.4% in 2021, the mobile C-arms segment controlled the industry. Due to their excellent imaging options for a variety of applications and outstanding flexibility for simple navigation, mobile C-arms are a growing market. In addition, the mobile C-Arms are lightweight, portable, and provide easy maneuverability, allowing for proper access to the internal organs.
Orthopedics and trauma, cardiology, oncology, gastroenterology, neurology, and others are included in the application type segment. The orthopedics and trauma segment will expand at the fastest CAGR of 6.6% during the forecast period. The market's expansion in this sector is driven by an increase in orthopedic surgery. The advancement of orthopedic surgeries' accuracy thanks to C-arm technology also fuels the market's expansion.
Hospitals, outpatient facilities, diagnostic facilities, and other entities make up the end-user segment. With a market share of roughly 35.6% and market revenue of 715.0 million, the hospital segment dominated the market in 2021. Due to better infrastructure and healthcare facilities, hospitals see a large number of patients, which propels the segment's expansion.
Regional Analysis
North America, Europe, South America, Asia Pacific, the Middle East, and Africa are among the geographic areas analyzed for the market. With a 40.3% revenue share in 2021, North America overtook Europe as the biggest market for C-Arms globally.
The C-Arms market is currently dominated by the North American region, which has a sizable target market and a well-established healthcare infrastructure. Additionally, the region's healthcare sector is home to a number of research and development projects that will fuel the market's expansion over the course of the forecast period. Along with this, the area is home to important industry players, which contributes to the expansion of the C-Arms market in the North American region.
Key Players
GE Healthcare Inc., Philips Healthcare, Siemens AG, Hologic Corp., BMI Biomedical International s.r.l., DMS Health Technologies, Medonica Co., Ltd., Gems Co. Ltd., and Shimadzu Corp. are a few of the major companies in the global market for C-arms devices.
